Navigation Links
Press briefings at International Microbicides Conference May 22-25
Date:5/17/2010

p>

1:30 2:30

Using ARVs as Prevention: Promise, Precautions and Potential for Drug Resistance

PrEP is a promising HIV prevention approach that involves use of antiretroviral (ARV) drugs that are normally used for treatment of HIV. But, should clinical trials find the strategy successful and PrEP is then rolled out as a prevention approach in at-risk communities, there is concern that virus resistant to the ARVs potentially would emerge and spread. What exactly is the risk and how can we avoid the consequences of "two trains on a collision course"? Two studies looked for answers. In one, a computer model that simulated the impact of PrEP on HIV prevention and drug resistance identified key factors that would influence the spread of HIV drug resistance. In a different take, laboratory studies suggest under what circumstances ARV-based gels could cause virus to become resistant. The same study tested different ARV gels to determine whether they can protect against strains of resistant virus known to be resistant against these ARVs or drugs in the same class.

Participants: Ume Abbas, M.D., Cleveland Clinic Foundation; Susan M. Schader, Ph.D., McGill University and McGill AIDS Centre, Montreal, Canada; John Mellors, M.D., University of Pittsburgh School of Medicine; Regina Osih, MD, MPH, University of the Witwatersrand, Johannesburg, South Africa. Moderator: Mitchell Warren, AVAC: Global Advocacy for HIV Prevention.

TUESDAY, May 25
1:15 2:00

Use of Lubricants, Unprotected Anal Sex and the Risk of HIV

The risk of acquiring HIV through unprotected anal sex is at least 20 times greater than with unprotected vaginal sex and increases if other infections are already present in the rectal lining. Could the use of lubricants at least certain kinds be another risk factor among men and women who engage in receptive anal intercourse? A study involving nearly 900 men and women in Baltimore and
'/>"/>

Contact: Lisa Rossi
rossil@upmc.edu
412-916-3315
Microbicides 2010 (International Conference on Microbicides)
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Higher blood pressure found in people living in urban areas
2. Fluctuating Blood Pressure Ups Stroke Risk
3. Press invitation, conference: Is medical ethics really in the best interest of the patient?
4. Suppressing activity of common intestinal bacteria reduces tumor growth
5. IMPAKT Breast Cancer Conference press program
6. Why is late-life depression harder to treat?
7. No One Antidepressant Raises Suicide Risk More Than Others
8. “You Are Very Pretty”, Says Myeexpert As It Releases A Book, Poetic Expressions, Dedicated To The Beauty of Women.
9. Magnet Therapy May Ease Hard-to-Treat Depression
10. IHRSA Expresses Its Ardent Support of America's First-Ever National Physical Activity Plan and Accepts Role as Co-Chair of Implementation Sub-Committee
11. Despite tests, high blood pressure hard to recognize in children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... a popular online store selling celebrity inspired fashion products, ... dresses. The company carries more than 1000 styles of ... a wide variety of summer events like wedding and ... quality trendy special occasion dresses and accessories. ... and cotton. Their products feature a wide range of ...
(Date:6/2/2015)... June 02, 2015 First Choice ... emergency rooms in the United States, named Kenneth Alan ... – Jones Road facility. , “We are pleased ... Houston-Jones Road facility,” said Dr. James M. Muzzarelli, Executive ... Dr. Totz received his undergraduate degree from St. Edwards ...
(Date:6/2/2015)... 2015 Thermi, formerly ThermiAesthetics, a ... successfully transitioned into its new company headquarters in ... company’s continued rapid worldwide expansion and houses the ... 25 Thermi employees, including those of the warehousing, ... “As one of the fastest growing aesthetic companies ...
(Date:6/2/2015)... MA (PRWEB) June 02, 2015 Join us ... Anniversary Awareness Walk in Honor of Rhonda Martin , who ... members have since dedicated their resources to raising awareness and ... seeks to raise awareness in hopes that there will be ... , All are welcome and encouraged to join the ...
(Date:6/1/2015)... 2015 The National Association of ... as a 2015-2016 inductee into its VIP Woman of ... distinction for leadership in business. NAPW is the nation’s ... than 700,000 members and over 200 operating Local Chapters. ... honor,” said NAPW President Star Jones. “Job satisfaction is ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2
... Results of two new studies suggest that low-dose estrogen ... experiencing menopausal hot flushes and bleeding. The June issue ... as effective as high-dose estrogen in treating menopausal symptoms. ... irregular bleeding.// , ...
... brain imaging techniques, scientists have indicated the patterns in ... to be stored or deleted. The study was done ... (MIT) and reported to the American Association for the ... ,The researchers coupled a number of different brain parts ...
... Australian researchers have identified a gene which allows the ... drugs.Plasmodium,is a single-celled organism which is transmitted to ... historically evaded control efforts by building resistance to virtually ... is hoped that the new discovery will lead to ...
... treat nausea, and research at the University of Sydney ... studies have shown that the active ingredients in ginger ... ingredient of chilli peppers and capsicum, a known pain ... the body called the vanilloid receptor, which sits on ...
... the hair loss associated with drug treatment for cancer. ,This ... a frequent side effect of cancer therapy and is often ... lives.// ,Currently, there is no effective way to stop ... attempt to minimise hair loss is to fit patients with ...
... researchers at Peterson Medical College, a strategy was developed ... Immunodeficiency Virus (HIV) out of dormancy in the cellular ... Samoan rainforest tree, and appears to stimulate the virus, ... body's immune system to detect and attack it.// ...
Cached Medicine News:Health News:An effective pain killer, 2Health News:Breakthrough in cancer therapy 2Health News:Prostratin- Drug to eradicate HIV 2
(Date:6/2/2015)... SAN FRANCISCO , June 2, 2015  Nektar ... Texas MD Anderson Cancer Center today announced a research ... evaluate NKTR-214, a CD122-biased cytokine designed to preferentially stimulate ... cells found naturally in the body.  CD122, which is ... a key signaling receptor that is known to increase ...
(Date:6/2/2015)... , June 2, 2015 Northstar ... first television and multi-media commercial advertisement, which it ... to promote SNORenz®, the company,s top selling product. ... the company,s past success with television advertising. Previous ... but this, more modern version takes an entertainment-oriented ...
(Date:6/2/2015)... und MADRID , ... Mündliche Präsentation (Abstract   10503), vorgestellt ... Clinical Oncology    PharmaMar teilt ... ( Janssen) Daten der multizentrischen Phase-3-Studie ... Verbesserung beim progressionsfreien Überleben (progression-free survival, PFS) ...
Breaking Medicine Technology:Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 2Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 3Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 4Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 5Nektar and MD Anderson Cancer Center Announce Phase 1/2 Clinical Research Collaboration for NKTR-214, a CD122-Biased Immuno-Stimulatory Cytokine 6Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 2PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 3PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 4PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 5PharmaMar gibt bekannt, Janssens Studie zeige, dass Trabectedin die Krankheitsbekämpfung bei Patienten mit fortgeschrittenem Weichgewebesarkom verbessert 6
... Ltd. (NYSE Amex: CPD ) announced that ... (Sun) have been extended until January 28, 2012 but ... which was originally set to expire in January 2010, ... and is being extended for an additional 1 year ...
... Pharmaceutical Company (NYSE: KVa/KVb) today announced the filing of its ... with the Securities and Exchange Commission.  As a result, the ... 2010 Form 10-K to enable its securities to continue trading ... is currently working on preparing and filing its quarterly reports ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma 2Caraco Pharmaceutical Laboratories, Ltd. Announces Extension and Future Termination of Distribution Agreements with Sun Pharma 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 2K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 3K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 4K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 5K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 6K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 7K-V Pharmaceutical Company Announces Filing of Fiscal Year 2010 Annual Report on Form 10-K With the Securities and Exchange Commission 8
Biocryl™ Acrylic Foldable Lens....
The STAAR ELASTIMIDE lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
... The Bausch & Lomb UV-Absorbing, Silicone Posterior ... for primary implantation for the visual correction ... age or older in whom the cataractous ... extraction methods. This device is intended to ...
... lenses are manufactured using the ... Perspex CQ UV PMMA material ... and single piece lenses. Unioptic ... both nonphaco and phaco styles. ...
Medicine Products: